Investor Hewlett Fund LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Hewlett Fund LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-06-25 13G/A PSTV / Plus Therapeutics, Inc. 2,006,552 0
2025-05-22 13G PSTV / Plus Therapeutics, Inc. 2,006,552
2024-05-07 13G BFRI / Biofrontera Inc. 504,168
2024-04-09 13G/A KWE / DEFSEC Technologies Inc. 0
2023-02-15 13G/A MYO / Myomo, Inc. 1,500,000 1,000,000
2023-01-17 13G MYO / Myomo, Inc. 1,500,000
2022-12-14 13G KWE / DEFSEC Technologies Inc. 265,000
2022-07-28 13G/A HTGM / HTG Molecular Diagnostics Inc 523,887 25,000
2022-01-04 13G/A HTGM / HTG Molecular Diagnostics Inc 408,887 523,887
2021-06-30 13G HTGM / HTG Molecular Diagnostics Inc 408,887
2021-04-30 13G SNPX / TAO Synergies Inc. 1,266,666
2017-07-11 13G MRIC / MRI Interventions Inc 562,500